Semnur Pharmaceuticals, Inc.
SMNR
$9.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 30,373.04% | 3.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15,174.67% | 50.23% | |||
| Operating Income | -15,174.67% | -50.23% | |||
| Income Before Tax | -15,174.67% | -50.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15,174.67% | -50.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15,174.67% | -50.23% | |||
| EBIT | -15,174.67% | -50.23% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -12,103.23% | -47.62% | |||
| Normalized Basic EPS | -12,025.64% | -50.00% | |||
| EPS Diluted | -12,103.23% | -47.62% | |||
| Normalized Diluted EPS | -12,025.64% | -50.00% | |||
| Average Basic Shares Outstanding | 26.05% | 0.00% | |||
| Average Diluted Shares Outstanding | 26.05% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||